Global Rabies Vaccine for Humans Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
LPI (LP Information)' newest research report, the “Rabies Vaccine for Humans Industry Forecast” looks at past sales and reviews total world Rabies Vaccine for Humans sales in 2022, providing a comprehensive analysis by region and market sector of projected Rabies Vaccine for Humans sales for 2023 through 2029. With Rabies Vaccine for Humans sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Vaccine for Humans industry.
This Insight Report provides a comprehensive analysis of the global Rabies Vaccine for Humans landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Vaccine for Humans portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rabies Vaccine for Humans market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Vaccine for Humans and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Vaccine for Humans.
The global Rabies Vaccine for Humans market size is projected to grow from US$ 1033 million in 2022 to US$ 1319.5 million in 2029; it is expected to grow at a CAGR of 1319.5 from 2023 to 2029.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 71% of the share.
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Vaccine for Humans market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Rabies Vaccine for Humans market?
What factors are driving Rabies Vaccine for Humans market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Vaccine for Humans market opportunities vary by end market size?
How does Rabies Vaccine for Humans break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
LPI (LP Information)' newest research report, the “Rabies Vaccine for Humans Industry Forecast” looks at past sales and reviews total world Rabies Vaccine for Humans sales in 2022, providing a comprehensive analysis by region and market sector of projected Rabies Vaccine for Humans sales for 2023 through 2029. With Rabies Vaccine for Humans sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Vaccine for Humans industry.
This Insight Report provides a comprehensive analysis of the global Rabies Vaccine for Humans landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Vaccine for Humans portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rabies Vaccine for Humans market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Vaccine for Humans and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Vaccine for Humans.
The global Rabies Vaccine for Humans market size is projected to grow from US$ 1033 million in 2022 to US$ 1319.5 million in 2029; it is expected to grow at a CAGR of 1319.5 from 2023 to 2029.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 71% of the share.
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Vaccine for Humans market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Preventative Vaccine
- Emergency Rabies Vaccine
- Pre-exposure prophylaxis
- Post-exposure prophylaxis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Sanofi
- GlaxoSmithKline
- Merck
- Chengda
- Yisheng
- Prcmise
- VACN
- Changsheng
- BCHT
- Hissen
What is the 10-year outlook for the global Rabies Vaccine for Humans market?
What factors are driving Rabies Vaccine for Humans market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Vaccine for Humans market opportunities vary by end market size?
How does Rabies Vaccine for Humans break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rabies Vaccine for Humans Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rabies Vaccine for Humans by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rabies Vaccine for Humans by Country/Region, 2018, 2022 & 2029
2.2 Rabies Vaccine for Humans Segment by Type
2.2.1 Preventative Vaccine
2.2.2 Emergency Rabies Vaccine
2.3 Rabies Vaccine for Humans Sales by Type
2.3.1 Global Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
2.3.2 Global Rabies Vaccine for Humans Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rabies Vaccine for Humans Sale Price by Type (2018-2023)
2.4 Rabies Vaccine for Humans Segment by Application
2.4.1 Pre-exposure prophylaxis
2.4.2 Post-exposure prophylaxis
2.5 Rabies Vaccine for Humans Sales by Application
2.5.1 Global Rabies Vaccine for Humans Sale Market Share by Application (2018-2023)
2.5.2 Global Rabies Vaccine for Humans Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rabies Vaccine for Humans Sale Price by Application (2018-2023)
3 GLOBAL RABIES VACCINE FOR HUMANS BY COMPANY
3.1 Global Rabies Vaccine for Humans Breakdown Data by Company
3.1.1 Global Rabies Vaccine for Humans Annual Sales by Company (2018-2023)
3.1.2 Global Rabies Vaccine for Humans Sales Market Share by Company (2018-2023)
3.2 Global Rabies Vaccine for Humans Annual Revenue by Company (2018-2023)
3.2.1 Global Rabies Vaccine for Humans Revenue by Company (2018-2023)
3.2.2 Global Rabies Vaccine for Humans Revenue Market Share by Company (2018-2023)
3.3 Global Rabies Vaccine for Humans Sale Price by Company
3.4 Key Manufacturers Rabies Vaccine for Humans Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Vaccine for Humans Product Location Distribution
3.4.2 Players Rabies Vaccine for Humans Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RABIES VACCINE FOR HUMANS BY GEOGRAPHIC REGION
4.1 World Historic Rabies Vaccine for Humans Market Size by Geographic Region (2018-2023)
4.1.1 Global Rabies Vaccine for Humans Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rabies Vaccine for Humans Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rabies Vaccine for Humans Market Size by Country/Region (2018-2023)
4.2.1 Global Rabies Vaccine for Humans Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rabies Vaccine for Humans Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rabies Vaccine for Humans Sales Growth
4.4 APAC Rabies Vaccine for Humans Sales Growth
4.5 Europe Rabies Vaccine for Humans Sales Growth
4.6 Middle East & Africa Rabies Vaccine for Humans Sales Growth
5 AMERICAS
5.1 Americas Rabies Vaccine for Humans Sales by Country
5.1.1 Americas Rabies Vaccine for Humans Sales by Country (2018-2023)
5.1.2 Americas Rabies Vaccine for Humans Revenue by Country (2018-2023)
5.2 Americas Rabies Vaccine for Humans Sales by Type
5.3 Americas Rabies Vaccine for Humans Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Vaccine for Humans Sales by Region
6.1.1 APAC Rabies Vaccine for Humans Sales by Region (2018-2023)
6.1.2 APAC Rabies Vaccine for Humans Revenue by Region (2018-2023)
6.2 APAC Rabies Vaccine for Humans Sales by Type
6.3 APAC Rabies Vaccine for Humans Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rabies Vaccine for Humans by Country
7.1.1 Europe Rabies Vaccine for Humans Sales by Country (2018-2023)
7.1.2 Europe Rabies Vaccine for Humans Revenue by Country (2018-2023)
7.2 Europe Rabies Vaccine for Humans Sales by Type
7.3 Europe Rabies Vaccine for Humans Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rabies Vaccine for Humans by Country
8.1.1 Middle East & Africa Rabies Vaccine for Humans Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rabies Vaccine for Humans Revenue by Country (2018-2023)
8.2 Middle East & Africa Rabies Vaccine for Humans Sales by Type
8.3 Middle East & Africa Rabies Vaccine for Humans Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Vaccine for Humans
10.3 Manufacturing Process Analysis of Rabies Vaccine for Humans
10.4 Industry Chain Structure of Rabies Vaccine for Humans
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Vaccine for Humans Distributors
11.3 Rabies Vaccine for Humans Customer
12 WORLD FORECAST REVIEW FOR RABIES VACCINE FOR HUMANS BY GEOGRAPHIC REGION
12.1 Global Rabies Vaccine for Humans Market Size Forecast by Region
12.1.1 Global Rabies Vaccine for Humans Forecast by Region (2024-2029)
12.1.2 Global Rabies Vaccine for Humans Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rabies Vaccine for Humans Forecast by Type
12.7 Global Rabies Vaccine for Humans Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Rabies Vaccine for Humans Product Portfolios and Specifications
13.1.3 Novartis Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Rabies Vaccine for Humans Product Portfolios and Specifications
13.2.3 Sanofi Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Rabies Vaccine for Humans Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Rabies Vaccine for Humans Product Portfolios and Specifications
13.4.3 Merck Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Chengda
13.5.1 Chengda Company Information
13.5.2 Chengda Rabies Vaccine for Humans Product Portfolios and Specifications
13.5.3 Chengda Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chengda Main Business Overview
13.5.5 Chengda Latest Developments
13.6 Yisheng
13.6.1 Yisheng Company Information
13.6.2 Yisheng Rabies Vaccine for Humans Product Portfolios and Specifications
13.6.3 Yisheng Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Yisheng Main Business Overview
13.6.5 Yisheng Latest Developments
13.7 Prcmise
13.7.1 Prcmise Company Information
13.7.2 Prcmise Rabies Vaccine for Humans Product Portfolios and Specifications
13.7.3 Prcmise Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Prcmise Main Business Overview
13.7.5 Prcmise Latest Developments
13.8 VACN
13.8.1 VACN Company Information
13.8.2 VACN Rabies Vaccine for Humans Product Portfolios and Specifications
13.8.3 VACN Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 VACN Main Business Overview
13.8.5 VACN Latest Developments
13.9 Changsheng
13.9.1 Changsheng Company Information
13.9.2 Changsheng Rabies Vaccine for Humans Product Portfolios and Specifications
13.9.3 Changsheng Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changsheng Main Business Overview
13.9.5 Changsheng Latest Developments
13.10 BCHT
13.10.1 BCHT Company Information
13.10.2 BCHT Rabies Vaccine for Humans Product Portfolios and Specifications
13.10.3 BCHT Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BCHT Main Business Overview
13.10.5 BCHT Latest Developments
13.11 Hissen
13.11.1 Hissen Company Information
13.11.2 Hissen Rabies Vaccine for Humans Product Portfolios and Specifications
13.11.3 Hissen Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hissen Main Business Overview
13.11.5 Hissen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rabies Vaccine for Humans Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rabies Vaccine for Humans by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rabies Vaccine for Humans by Country/Region, 2018, 2022 & 2029
2.2 Rabies Vaccine for Humans Segment by Type
2.2.1 Preventative Vaccine
2.2.2 Emergency Rabies Vaccine
2.3 Rabies Vaccine for Humans Sales by Type
2.3.1 Global Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
2.3.2 Global Rabies Vaccine for Humans Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rabies Vaccine for Humans Sale Price by Type (2018-2023)
2.4 Rabies Vaccine for Humans Segment by Application
2.4.1 Pre-exposure prophylaxis
2.4.2 Post-exposure prophylaxis
2.5 Rabies Vaccine for Humans Sales by Application
2.5.1 Global Rabies Vaccine for Humans Sale Market Share by Application (2018-2023)
2.5.2 Global Rabies Vaccine for Humans Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rabies Vaccine for Humans Sale Price by Application (2018-2023)
3 GLOBAL RABIES VACCINE FOR HUMANS BY COMPANY
3.1 Global Rabies Vaccine for Humans Breakdown Data by Company
3.1.1 Global Rabies Vaccine for Humans Annual Sales by Company (2018-2023)
3.1.2 Global Rabies Vaccine for Humans Sales Market Share by Company (2018-2023)
3.2 Global Rabies Vaccine for Humans Annual Revenue by Company (2018-2023)
3.2.1 Global Rabies Vaccine for Humans Revenue by Company (2018-2023)
3.2.2 Global Rabies Vaccine for Humans Revenue Market Share by Company (2018-2023)
3.3 Global Rabies Vaccine for Humans Sale Price by Company
3.4 Key Manufacturers Rabies Vaccine for Humans Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Vaccine for Humans Product Location Distribution
3.4.2 Players Rabies Vaccine for Humans Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RABIES VACCINE FOR HUMANS BY GEOGRAPHIC REGION
4.1 World Historic Rabies Vaccine for Humans Market Size by Geographic Region (2018-2023)
4.1.1 Global Rabies Vaccine for Humans Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rabies Vaccine for Humans Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rabies Vaccine for Humans Market Size by Country/Region (2018-2023)
4.2.1 Global Rabies Vaccine for Humans Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rabies Vaccine for Humans Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rabies Vaccine for Humans Sales Growth
4.4 APAC Rabies Vaccine for Humans Sales Growth
4.5 Europe Rabies Vaccine for Humans Sales Growth
4.6 Middle East & Africa Rabies Vaccine for Humans Sales Growth
5 AMERICAS
5.1 Americas Rabies Vaccine for Humans Sales by Country
5.1.1 Americas Rabies Vaccine for Humans Sales by Country (2018-2023)
5.1.2 Americas Rabies Vaccine for Humans Revenue by Country (2018-2023)
5.2 Americas Rabies Vaccine for Humans Sales by Type
5.3 Americas Rabies Vaccine for Humans Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Vaccine for Humans Sales by Region
6.1.1 APAC Rabies Vaccine for Humans Sales by Region (2018-2023)
6.1.2 APAC Rabies Vaccine for Humans Revenue by Region (2018-2023)
6.2 APAC Rabies Vaccine for Humans Sales by Type
6.3 APAC Rabies Vaccine for Humans Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rabies Vaccine for Humans by Country
7.1.1 Europe Rabies Vaccine for Humans Sales by Country (2018-2023)
7.1.2 Europe Rabies Vaccine for Humans Revenue by Country (2018-2023)
7.2 Europe Rabies Vaccine for Humans Sales by Type
7.3 Europe Rabies Vaccine for Humans Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rabies Vaccine for Humans by Country
8.1.1 Middle East & Africa Rabies Vaccine for Humans Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rabies Vaccine for Humans Revenue by Country (2018-2023)
8.2 Middle East & Africa Rabies Vaccine for Humans Sales by Type
8.3 Middle East & Africa Rabies Vaccine for Humans Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Vaccine for Humans
10.3 Manufacturing Process Analysis of Rabies Vaccine for Humans
10.4 Industry Chain Structure of Rabies Vaccine for Humans
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Vaccine for Humans Distributors
11.3 Rabies Vaccine for Humans Customer
12 WORLD FORECAST REVIEW FOR RABIES VACCINE FOR HUMANS BY GEOGRAPHIC REGION
12.1 Global Rabies Vaccine for Humans Market Size Forecast by Region
12.1.1 Global Rabies Vaccine for Humans Forecast by Region (2024-2029)
12.1.2 Global Rabies Vaccine for Humans Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rabies Vaccine for Humans Forecast by Type
12.7 Global Rabies Vaccine for Humans Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Rabies Vaccine for Humans Product Portfolios and Specifications
13.1.3 Novartis Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Rabies Vaccine for Humans Product Portfolios and Specifications
13.2.3 Sanofi Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Rabies Vaccine for Humans Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Rabies Vaccine for Humans Product Portfolios and Specifications
13.4.3 Merck Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Chengda
13.5.1 Chengda Company Information
13.5.2 Chengda Rabies Vaccine for Humans Product Portfolios and Specifications
13.5.3 Chengda Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chengda Main Business Overview
13.5.5 Chengda Latest Developments
13.6 Yisheng
13.6.1 Yisheng Company Information
13.6.2 Yisheng Rabies Vaccine for Humans Product Portfolios and Specifications
13.6.3 Yisheng Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Yisheng Main Business Overview
13.6.5 Yisheng Latest Developments
13.7 Prcmise
13.7.1 Prcmise Company Information
13.7.2 Prcmise Rabies Vaccine for Humans Product Portfolios and Specifications
13.7.3 Prcmise Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Prcmise Main Business Overview
13.7.5 Prcmise Latest Developments
13.8 VACN
13.8.1 VACN Company Information
13.8.2 VACN Rabies Vaccine for Humans Product Portfolios and Specifications
13.8.3 VACN Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 VACN Main Business Overview
13.8.5 VACN Latest Developments
13.9 Changsheng
13.9.1 Changsheng Company Information
13.9.2 Changsheng Rabies Vaccine for Humans Product Portfolios and Specifications
13.9.3 Changsheng Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changsheng Main Business Overview
13.9.5 Changsheng Latest Developments
13.10 BCHT
13.10.1 BCHT Company Information
13.10.2 BCHT Rabies Vaccine for Humans Product Portfolios and Specifications
13.10.3 BCHT Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BCHT Main Business Overview
13.10.5 BCHT Latest Developments
13.11 Hissen
13.11.1 Hissen Company Information
13.11.2 Hissen Rabies Vaccine for Humans Product Portfolios and Specifications
13.11.3 Hissen Rabies Vaccine for Humans Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hissen Main Business Overview
13.11.5 Hissen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rabies Vaccine for Humans Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rabies Vaccine for Humans Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Preventative Vaccine
Table 4. Major Players of Emergency Rabies Vaccine
Table 5. Global Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 6. Global Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Table 7. Global Rabies Vaccine for Humans Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rabies Vaccine for Humans Revenue Market Share by Type (2018-2023)
Table 9. Global Rabies Vaccine for Humans Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 11. Global Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Table 12. Global Rabies Vaccine for Humans Revenue by Application (2018-2023)
Table 13. Global Rabies Vaccine for Humans Revenue Market Share by Application (2018-2023)
Table 14. Global Rabies Vaccine for Humans Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Rabies Vaccine for Humans Sales by Company (2018-2023) & (K Units)
Table 16. Global Rabies Vaccine for Humans Sales Market Share by Company (2018-2023)
Table 17. Global Rabies Vaccine for Humans Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rabies Vaccine for Humans Revenue Market Share by Company (2018-2023)
Table 19. Global Rabies Vaccine for Humans Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Rabies Vaccine for Humans Producing Area Distribution and Sales Area
Table 21. Players Rabies Vaccine for Humans Products Offered
Table 22. Rabies Vaccine for Humans Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rabies Vaccine for Humans Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Rabies Vaccine for Humans Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rabies Vaccine for Humans Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rabies Vaccine for Humans Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rabies Vaccine for Humans Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Rabies Vaccine for Humans Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rabies Vaccine for Humans Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rabies Vaccine for Humans Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rabies Vaccine for Humans Sales by Country (2018-2023) & (K Units)
Table 34. Americas Rabies Vaccine for Humans Sales Market Share by Country (2018-2023)
Table 35. Americas Rabies Vaccine for Humans Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rabies Vaccine for Humans Revenue Market Share by Country (2018-2023)
Table 37. Americas Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 38. Americas Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 39. APAC Rabies Vaccine for Humans Sales by Region (2018-2023) & (K Units)
Table 40. APAC Rabies Vaccine for Humans Sales Market Share by Region (2018-2023)
Table 41. APAC Rabies Vaccine for Humans Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rabies Vaccine for Humans Revenue Market Share by Region (2018-2023)
Table 43. APAC Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 44. APAC Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 45. Europe Rabies Vaccine for Humans Sales by Country (2018-2023) & (K Units)
Table 46. Europe Rabies Vaccine for Humans Sales Market Share by Country (2018-2023)
Table 47. Europe Rabies Vaccine for Humans Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rabies Vaccine for Humans Revenue Market Share by Country (2018-2023)
Table 49. Europe Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 50. Europe Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Rabies Vaccine for Humans Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rabies Vaccine for Humans Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rabies Vaccine for Humans Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Rabies Vaccine for Humans
Table 58. Key Market Challenges & Risks of Rabies Vaccine for Humans
Table 59. Key Industry Trends of Rabies Vaccine for Humans
Table 60. Rabies Vaccine for Humans Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rabies Vaccine for Humans Distributors List
Table 63. Rabies Vaccine for Humans Customer List
Table 64. Global Rabies Vaccine for Humans Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Rabies Vaccine for Humans Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rabies Vaccine for Humans Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Rabies Vaccine for Humans Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rabies Vaccine for Humans Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Rabies Vaccine for Humans Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rabies Vaccine for Humans Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Rabies Vaccine for Humans Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rabies Vaccine for Humans Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Rabies Vaccine for Humans Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rabies Vaccine for Humans Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Rabies Vaccine for Humans Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rabies Vaccine for Humans Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Rabies Vaccine for Humans Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Rabies Vaccine for Humans Product Portfolios and Specifications
Table 80. Novartis Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Sanofi Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Rabies Vaccine for Humans Product Portfolios and Specifications
Table 85. Sanofi Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. GlaxoSmithKline Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 89. GlaxoSmithKline Rabies Vaccine for Humans Product Portfolios and Specifications
Table 90. GlaxoSmithKline Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. GlaxoSmithKline Main Business
Table 92. GlaxoSmithKline Latest Developments
Table 93. Merck Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Rabies Vaccine for Humans Product Portfolios and Specifications
Table 95. Merck Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Chengda Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 99. Chengda Rabies Vaccine for Humans Product Portfolios and Specifications
Table 100. Chengda Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Chengda Main Business
Table 102. Chengda Latest Developments
Table 103. Yisheng Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 104. Yisheng Rabies Vaccine for Humans Product Portfolios and Specifications
Table 105. Yisheng Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Yisheng Main Business
Table 107. Yisheng Latest Developments
Table 108. Prcmise Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 109. Prcmise Rabies Vaccine for Humans Product Portfolios and Specifications
Table 110. Prcmise Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Prcmise Main Business
Table 112. Prcmise Latest Developments
Table 113. VACN Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 114. VACN Rabies Vaccine for Humans Product Portfolios and Specifications
Table 115. VACN Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. VACN Main Business
Table 117. VACN Latest Developments
Table 118. Changsheng Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 119. Changsheng Rabies Vaccine for Humans Product Portfolios and Specifications
Table 120. Changsheng Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Changsheng Main Business
Table 122. Changsheng Latest Developments
Table 123. BCHT Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 124. BCHT Rabies Vaccine for Humans Product Portfolios and Specifications
Table 125. BCHT Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. BCHT Main Business
Table 127. BCHT Latest Developments
Table 128. Hissen Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 129. Hissen Rabies Vaccine for Humans Product Portfolios and Specifications
Table 130. Hissen Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Hissen Main Business
Table 132. Hissen Latest Developments
Table 1. Rabies Vaccine for Humans Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rabies Vaccine for Humans Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Preventative Vaccine
Table 4. Major Players of Emergency Rabies Vaccine
Table 5. Global Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 6. Global Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Table 7. Global Rabies Vaccine for Humans Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rabies Vaccine for Humans Revenue Market Share by Type (2018-2023)
Table 9. Global Rabies Vaccine for Humans Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 11. Global Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Table 12. Global Rabies Vaccine for Humans Revenue by Application (2018-2023)
Table 13. Global Rabies Vaccine for Humans Revenue Market Share by Application (2018-2023)
Table 14. Global Rabies Vaccine for Humans Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Rabies Vaccine for Humans Sales by Company (2018-2023) & (K Units)
Table 16. Global Rabies Vaccine for Humans Sales Market Share by Company (2018-2023)
Table 17. Global Rabies Vaccine for Humans Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rabies Vaccine for Humans Revenue Market Share by Company (2018-2023)
Table 19. Global Rabies Vaccine for Humans Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Rabies Vaccine for Humans Producing Area Distribution and Sales Area
Table 21. Players Rabies Vaccine for Humans Products Offered
Table 22. Rabies Vaccine for Humans Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rabies Vaccine for Humans Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Rabies Vaccine for Humans Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rabies Vaccine for Humans Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rabies Vaccine for Humans Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rabies Vaccine for Humans Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Rabies Vaccine for Humans Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rabies Vaccine for Humans Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rabies Vaccine for Humans Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rabies Vaccine for Humans Sales by Country (2018-2023) & (K Units)
Table 34. Americas Rabies Vaccine for Humans Sales Market Share by Country (2018-2023)
Table 35. Americas Rabies Vaccine for Humans Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rabies Vaccine for Humans Revenue Market Share by Country (2018-2023)
Table 37. Americas Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 38. Americas Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 39. APAC Rabies Vaccine for Humans Sales by Region (2018-2023) & (K Units)
Table 40. APAC Rabies Vaccine for Humans Sales Market Share by Region (2018-2023)
Table 41. APAC Rabies Vaccine for Humans Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rabies Vaccine for Humans Revenue Market Share by Region (2018-2023)
Table 43. APAC Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 44. APAC Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 45. Europe Rabies Vaccine for Humans Sales by Country (2018-2023) & (K Units)
Table 46. Europe Rabies Vaccine for Humans Sales Market Share by Country (2018-2023)
Table 47. Europe Rabies Vaccine for Humans Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rabies Vaccine for Humans Revenue Market Share by Country (2018-2023)
Table 49. Europe Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 50. Europe Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Rabies Vaccine for Humans Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rabies Vaccine for Humans Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rabies Vaccine for Humans Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rabies Vaccine for Humans Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Rabies Vaccine for Humans Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Rabies Vaccine for Humans
Table 58. Key Market Challenges & Risks of Rabies Vaccine for Humans
Table 59. Key Industry Trends of Rabies Vaccine for Humans
Table 60. Rabies Vaccine for Humans Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rabies Vaccine for Humans Distributors List
Table 63. Rabies Vaccine for Humans Customer List
Table 64. Global Rabies Vaccine for Humans Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Rabies Vaccine for Humans Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rabies Vaccine for Humans Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Rabies Vaccine for Humans Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rabies Vaccine for Humans Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Rabies Vaccine for Humans Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rabies Vaccine for Humans Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Rabies Vaccine for Humans Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rabies Vaccine for Humans Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Rabies Vaccine for Humans Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rabies Vaccine for Humans Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Rabies Vaccine for Humans Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rabies Vaccine for Humans Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Rabies Vaccine for Humans Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Rabies Vaccine for Humans Product Portfolios and Specifications
Table 80. Novartis Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Sanofi Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Rabies Vaccine for Humans Product Portfolios and Specifications
Table 85. Sanofi Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. GlaxoSmithKline Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 89. GlaxoSmithKline Rabies Vaccine for Humans Product Portfolios and Specifications
Table 90. GlaxoSmithKline Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. GlaxoSmithKline Main Business
Table 92. GlaxoSmithKline Latest Developments
Table 93. Merck Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Rabies Vaccine for Humans Product Portfolios and Specifications
Table 95. Merck Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Chengda Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 99. Chengda Rabies Vaccine for Humans Product Portfolios and Specifications
Table 100. Chengda Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Chengda Main Business
Table 102. Chengda Latest Developments
Table 103. Yisheng Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 104. Yisheng Rabies Vaccine for Humans Product Portfolios and Specifications
Table 105. Yisheng Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Yisheng Main Business
Table 107. Yisheng Latest Developments
Table 108. Prcmise Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 109. Prcmise Rabies Vaccine for Humans Product Portfolios and Specifications
Table 110. Prcmise Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Prcmise Main Business
Table 112. Prcmise Latest Developments
Table 113. VACN Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 114. VACN Rabies Vaccine for Humans Product Portfolios and Specifications
Table 115. VACN Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. VACN Main Business
Table 117. VACN Latest Developments
Table 118. Changsheng Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 119. Changsheng Rabies Vaccine for Humans Product Portfolios and Specifications
Table 120. Changsheng Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Changsheng Main Business
Table 122. Changsheng Latest Developments
Table 123. BCHT Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 124. BCHT Rabies Vaccine for Humans Product Portfolios and Specifications
Table 125. BCHT Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. BCHT Main Business
Table 127. BCHT Latest Developments
Table 128. Hissen Basic Information, Rabies Vaccine for Humans Manufacturing Base, Sales Area and Its Competitors
Table 129. Hissen Rabies Vaccine for Humans Product Portfolios and Specifications
Table 130. Hissen Rabies Vaccine for Humans Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Hissen Main Business
Table 132. Hissen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rabies Vaccine for Humans
Figure 2. Rabies Vaccine for Humans Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Vaccine for Humans Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rabies Vaccine for Humans Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rabies Vaccine for Humans Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Preventative Vaccine
Figure 10. Product Picture of Emergency Rabies Vaccine
Figure 11. Global Rabies Vaccine for Humans Sales Market Share by Type in 2022
Figure 12. Global Rabies Vaccine for Humans Revenue Market Share by Type (2018-2023)
Figure 13. Rabies Vaccine for Humans Consumed in Pre-exposure prophylaxis
Figure 14. Global Rabies Vaccine for Humans Market: Pre-exposure prophylaxis (2018-2023) & (K Units)
Figure 15. Rabies Vaccine for Humans Consumed in Post-exposure prophylaxis
Figure 16. Global Rabies Vaccine for Humans Market: Post-exposure prophylaxis (2018-2023) & (K Units)
Figure 17. Global Rabies Vaccine for Humans Sales Market Share by Application (2022)
Figure 18. Global Rabies Vaccine for Humans Revenue Market Share by Application in 2022
Figure 19. Rabies Vaccine for Humans Sales Market by Company in 2022 (K Units)
Figure 20. Global Rabies Vaccine for Humans Sales Market Share by Company in 2022
Figure 21. Rabies Vaccine for Humans Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Rabies Vaccine for Humans Revenue Market Share by Company in 2022
Figure 23. Global Rabies Vaccine for Humans Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Rabies Vaccine for Humans Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Rabies Vaccine for Humans Sales 2018-2023 (K Units)
Figure 26. Americas Rabies Vaccine for Humans Revenue 2018-2023 ($ Millions)
Figure 27. APAC Rabies Vaccine for Humans Sales 2018-2023 (K Units)
Figure 28. APAC Rabies Vaccine for Humans Revenue 2018-2023 ($ Millions)
Figure 29. Europe Rabies Vaccine for Humans Sales 2018-2023 (K Units)
Figure 30. Europe Rabies Vaccine for Humans Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Rabies Vaccine for Humans Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Rabies Vaccine for Humans Revenue 2018-2023 ($ Millions)
Figure 33. Americas Rabies Vaccine for Humans Sales Market Share by Country in 2022
Figure 34. Americas Rabies Vaccine for Humans Revenue Market Share by Country in 2022
Figure 35. Americas Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Figure 36. Americas Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Figure 37. United States Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Rabies Vaccine for Humans Sales Market Share by Region in 2022
Figure 42. APAC Rabies Vaccine for Humans Revenue Market Share by Regions in 2022
Figure 43. APAC Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Figure 44. APAC Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Figure 45. China Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Rabies Vaccine for Humans Sales Market Share by Country in 2022
Figure 53. Europe Rabies Vaccine for Humans Revenue Market Share by Country in 2022
Figure 54. Europe Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Figure 55. Europe Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Figure 56. Germany Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Rabies Vaccine for Humans Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Figure 65. Egypt Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Rabies Vaccine for Humans in 2022
Figure 71. Manufacturing Process Analysis of Rabies Vaccine for Humans
Figure 72. Industry Chain Structure of Rabies Vaccine for Humans
Figure 73. Channels of Distribution
Figure 74. Global Rabies Vaccine for Humans Sales Market Forecast by Region (2024-2029)
Figure 75. Global Rabies Vaccine for Humans Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Rabies Vaccine for Humans Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Rabies Vaccine for Humans Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Rabies Vaccine for Humans Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Rabies Vaccine for Humans Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Rabies Vaccine for Humans
Figure 2. Rabies Vaccine for Humans Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Vaccine for Humans Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rabies Vaccine for Humans Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rabies Vaccine for Humans Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Preventative Vaccine
Figure 10. Product Picture of Emergency Rabies Vaccine
Figure 11. Global Rabies Vaccine for Humans Sales Market Share by Type in 2022
Figure 12. Global Rabies Vaccine for Humans Revenue Market Share by Type (2018-2023)
Figure 13. Rabies Vaccine for Humans Consumed in Pre-exposure prophylaxis
Figure 14. Global Rabies Vaccine for Humans Market: Pre-exposure prophylaxis (2018-2023) & (K Units)
Figure 15. Rabies Vaccine for Humans Consumed in Post-exposure prophylaxis
Figure 16. Global Rabies Vaccine for Humans Market: Post-exposure prophylaxis (2018-2023) & (K Units)
Figure 17. Global Rabies Vaccine for Humans Sales Market Share by Application (2022)
Figure 18. Global Rabies Vaccine for Humans Revenue Market Share by Application in 2022
Figure 19. Rabies Vaccine for Humans Sales Market by Company in 2022 (K Units)
Figure 20. Global Rabies Vaccine for Humans Sales Market Share by Company in 2022
Figure 21. Rabies Vaccine for Humans Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Rabies Vaccine for Humans Revenue Market Share by Company in 2022
Figure 23. Global Rabies Vaccine for Humans Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Rabies Vaccine for Humans Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Rabies Vaccine for Humans Sales 2018-2023 (K Units)
Figure 26. Americas Rabies Vaccine for Humans Revenue 2018-2023 ($ Millions)
Figure 27. APAC Rabies Vaccine for Humans Sales 2018-2023 (K Units)
Figure 28. APAC Rabies Vaccine for Humans Revenue 2018-2023 ($ Millions)
Figure 29. Europe Rabies Vaccine for Humans Sales 2018-2023 (K Units)
Figure 30. Europe Rabies Vaccine for Humans Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Rabies Vaccine for Humans Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Rabies Vaccine for Humans Revenue 2018-2023 ($ Millions)
Figure 33. Americas Rabies Vaccine for Humans Sales Market Share by Country in 2022
Figure 34. Americas Rabies Vaccine for Humans Revenue Market Share by Country in 2022
Figure 35. Americas Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Figure 36. Americas Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Figure 37. United States Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Rabies Vaccine for Humans Sales Market Share by Region in 2022
Figure 42. APAC Rabies Vaccine for Humans Revenue Market Share by Regions in 2022
Figure 43. APAC Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Figure 44. APAC Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Figure 45. China Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Rabies Vaccine for Humans Sales Market Share by Country in 2022
Figure 53. Europe Rabies Vaccine for Humans Revenue Market Share by Country in 2022
Figure 54. Europe Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Figure 55. Europe Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Figure 56. Germany Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Rabies Vaccine for Humans Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Application (2018-2023)
Figure 65. Egypt Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Rabies Vaccine for Humans Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Rabies Vaccine for Humans in 2022
Figure 71. Manufacturing Process Analysis of Rabies Vaccine for Humans
Figure 72. Industry Chain Structure of Rabies Vaccine for Humans
Figure 73. Channels of Distribution
Figure 74. Global Rabies Vaccine for Humans Sales Market Forecast by Region (2024-2029)
Figure 75. Global Rabies Vaccine for Humans Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Rabies Vaccine for Humans Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Rabies Vaccine for Humans Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Rabies Vaccine for Humans Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Rabies Vaccine for Humans Revenue Market Share Forecast by Application (2024-2029)
